frameworks was obtained from a national blueprint for a quality framework, other existing frameworks, input from patient organisations and other relevant parties. The frameworks were sent for review to all members of the scientific societies and consequently tested during two peer reviews per speciality. Improvements to the quality framework were made where appropriate and approved at the general assembly. Results: All nine scientific societies created a quality framework. The same design was used for all frameworks: four quality domains (evaluating care, team performance, patient perspective, and professional development) with multiple aspects (e.g. evaluation of patient records, multidisciplinary meetings, measuring patient satisfaction and knowledge sharing). A grading system was developed with five levels, ranging from excellent (being an example to others) to very poor (the necessity to improve the aspect within a maximum of six months). Differences in settings necessitated adaptations to the framework, e.g. for regional laboratories for medical microbiology or private clinics. In addition, the development of the quality frameworks resulted in changes in other parts of the peer review methodology, e.g. the regulations and the format for the peer review report. In addition, a manual for developing a quality framework for peer review was developed. Conclusion: Using a uniform design, relevant frameworks for peer reviews of medical specialists were developed. The combination of joint and individual meetings resulted in learning from one another and consequently applying this knowledge for the participant's own quality framework. These quality frameworks will support uniform decision making on where quality improvement is required from the groups of medical specialists. Objectives: Regulation is a system level policy used to improve healthcare quality. However, regulation is criticised as ineffective and reactive. In response, regulatory agencies are increasingly concerned with the assessment of improvement capability. Assessing improvement capability is important because organisations with more improvement capability may be more adept to deal with problems and bring about improvement for themselves, while those with limited improvement capability may need more external support and intervention. However, little is known about regulatory perspectives of improvement capability and there are few valid and reliable assessment instruments. Therefore, this study aims to understand how improvement capability is conceptualised and assessed by six national healthcare regulatory agencies across the four countries of the UK. Methods: Hospital care was the study focus as this accounts for the majority of UK healthcare expenditure and a comparative qualitative study was conducted. All six UK healthcare organisational regulatory agencies participated in the study. Three data sources from each agency were used, including regulatory policy documents (n = 90), interviews from a cross-section of regulatory staff (n = 48), and assessment reports (n = 30) during the period 2013-2015. Content and thematic analysis was used to robustly analyse the data using an a priori coding framework. The framework was inductively developed from a comprehensive literature review of 70 instruments used for the assessment of improvement capability and consisted of eight dimensions. They were: Organisational culture; Leadership commitment; Employee commitment; Service user focus; Stakeholder and supplier focus; Process improvement and learning; Strategy and governance; and Data and performance. Manchester Business School ethics process was followed and approval granted.
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Results: The study finds that regulatory agencies want to assess improvement capability accurately, to support the development of more effective system level interventions to ensure improved healthcare quality. The analysis shows that the dimensions of process improvement and learning and strategy and governance were most frequently used. Other dimensions were found less frequently with service-user focus being the least frequent, and this skewed pattern was consistent across agencies. Three themes emerge from the empirical data. First, it is problematic to define and operationalise improvement capability. Policy document and interviews stress the importance of developing improvement capability but do not articulate consistently what is meant by improvement capability. Second, assessments rely on out-of-date and infrequently measured data. Third, there is variable understanding of improvement capability, leading to variation and assessment bias through self-confessed knowledge gaps.
Conclusion:
The study set out to consider how regulatory agencies assess improvement capability. The analysis shows that whilst agencies aim to assess improvement capability, two dimensions are used more frequently than others. This may be due to the difficulty in operationalising improvement capability dimensions, due to measurement, knowledge and practice gaps. The study highlights the need for regulatory agencies to further conceptualise improvement capability to inform assessment and development. This will strengthen agencies assessment, diagnosis and prediction of performance trajectories and support the development of tailored regulatory interventions. Abstracts of care; however little is known about how boards enact quality governance and lead quality improvement (QI). The objectives of this study were to explore how quality governance is enacted by hospital boards and to identify the characteristics of boards with a hghly developed approach to quality governance. Methods: We did fieldwork in 15 healthcare provider organisations in England as part of an evaluation of a board-level organisational development intervention (iQUASER). The data comprised interviews with board members (n = 66), observations of board meetings (60 hours) and documents (30 sets of board meeting papers and 15 Quality Accounts). We analysed the data using a framework we developed from existing research on the link between board practices and quality of care. Our analysis mapped the variation in how quality governance was enacted at board-level. We then used our findings to construct a measure of quality governance maturity. We used this measure to rate each organization in our study on the basis of the maturity of their approach to quality governance. We then compared organisations with a 'high' and 'low' quality governance maturity. This study received exemption from NHS Research Ethics processes. Informed consent was obtained from all participants. Results: We found that boards of organisations with more highly developed quality governance prioritize QI, balance attention to short term priorities with a long term investment in QI, use data for QI, not just quality assurance, engage staff and patients in QI, and have a culture of continuous improvement. These characteristics were often enabled and facilitated by board-level clinical leaders.
This study contributes to an understanding of how quality governance is enacted by boards, and, in particular, the role of board-level clinician-manager 'hybrids'. Our findings can help organisations improve their board-level quality governance.
ISQUA17-3046 REGULATORY ACTION TO REDUCE BURNOUT AND BARRIERS TO TREATMENT-SEEKING AMONG PROVIDERS

M. STAZ * , H. CHAUDHRY, and A. HENGERER
FEDERATION OF STATE MEDICAL BOARDS, Euless, United States
Objectives: Participants at this session will be better able to:
1. Describe how burnout affects provider wellness and presents threats to competence and patient safety, 2. Explain how regulatory processes can impede provider willingness to report and seek treatment for issues of mental health, substance use, or other symptoms of burnout, and 3. Discuss an emerging evidence-informed medical regulatory initiative from the United States that highlights best practices for identifying potential risks to patients without increasing stigma associated with treatmentseeking among providers.
Methods: The presenter will describe the current state of physician burnout, including prevalence among medical specialties, contributing factors, and proposed solutions. The position of the medical regulatory authority with respect to burnout will then be considered, using illustrations from discussions of the Federation of State Medical Boards' (FSMB) Workgroup on Physician Wellness and Burnout. The chief responsibility of any medical regulatory authority is to protect the health and safety of patients through licensing, disciplinary, and other regulatory processes for physicians. In scenarios involving burnout, however, protection of public health occurs by focusing first on the health of the provider. This is a challenging shift of perspective for many regulators and forces them to achieve a difficult balance between seeking enough information from physicians to be capable of adequately identifying risks to patients, without increasing stigma around burnout and treatment-seeking, thereby inadvertently causing a barrier to wellness among physicians. Application questionnaires used during licensing processes are an area being looked at in the United States by the FSMB, as this is the primary means by which medical regulators gather information about physicians seeking licensure. Participants in this session will be provided with an overview of licensing processes in American jurisdictions with emphasis on levers for assessing potential risks to patients based on provider health.
Best practices will be highlighted for phrasing questions in a way that does not lead to greater stigma about symptoms of burnout, including focusing only on impairment that can interfere with a physician's ability to practice medicine safely, rather than seeking information about a history of illness that may not impact patient care. Regulators must also be mindful of recent data demonstrating a reluctance on the part of providers to report symptoms of burnout for fear they may impact their ability to obtain unrestricted licensure. Results: Session participants will be shown concrete examples of licensing and registration questions that address impairment, but avoid contributing to further stigma around burnout or present barriers to reporting and treatment-seeking. Conclusion: Medical regulatory authorities' duty to protect the public includes a responsibility to ensure physician wellness. While numerous systems factors contribute to the prevalence of burnout among healthcare providers, regulators are working to address burnout by focusing first on the processes related to licensure and discipline that are under their sole purview. Lessons from this ongoing work will be applicable to other areas of healthcare governance, including accreditation and employment processes. Reference Objectives: Regulation of the health-care industry is considered to be an important tool to improve quality of care, however, the literature evaluating the effectiveness of accreditation internationally is Abstracts
